Related Experiment Video
Updated: Dec 17, 2025
09:02
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
3.0K
Hypoxia-responsive nanoparticles for tumor-targeted drug delivery
Yuce Li1, Jueun Jeon1, Jae Hyung Park2
1School of Chemical Engineering, College of Engineering, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
Cancer Letters
|June 26, 2020
Summary
Hypoxia, or low oxygen, in tumors worsens prognosis. Researchers are developing hypoxia-responsive nanoparticles (HR-NPs) to target cancer cells in these specific tumor microenvironments for improved therapy.
Area of Science:
- Biomedical Engineering
- Oncology
- Nanotechnology
Background:
- Intratumoral hypoxia is a negative prognostic factor in solid tumors.
- Hypoxic microenvironments correlate with increased tumor aggressiveness and reduced treatment efficacy.
- Tumor cells under hypoxia exhibit unique metabolic and gene expression profiles, enabling targeted strategies.
Purpose of the Study:
- To review hypoxia-responsive molecular structures used in nanoparticle construction.
- To present strategies for utilizing hypoxia-responsive nanoparticles (HR-NPs) in cancer therapy.
- To highlight recent advancements in HR-NPs for tumor-targeted drug delivery.
Main Methods:
- Review of literature on hypoxia-responsive molecular structures.
- Analysis of strategies for designing and applying HR-NPs.
- Synthesis of recent research on HR-NPs in cancer treatment.
Main Results:
- Identification of various hypoxia-responsive moieties for HR-NP design.
- Demonstration of effective drug delivery to hypoxic tumor sites using HR-NPs.
- Evidence of enhanced therapeutic outcomes with HR-NPs in preclinical studies.
Conclusions:
- HR-NPs offer a promising approach to exploit the hypoxic tumor microenvironment for targeted cancer therapy.
- The development of novel HR-NPs is advancing efficient drug delivery and improving treatment efficacy.
- Targeted drug delivery systems leveraging hypoxia are crucial for overcoming therapeutic challenges in solid tumors.
